Loading

Emerging opportunities and challenges in bi-/multi-specific antibody drug development

28 Oct 2024

11:20 - 12:20

Bi/Multispecifics

Emerging opportunities and challenges in bi-/multi-specific antibody drug development

The opportunity in oncology and autoimmune disease
The challenge to develop Bi/Multi Specifics Antibodies
Safety considerations on Bi/Multi Specifics antibodies.

Industry Experts

Zeck Huang, Sr. Director Nonclinical Lead - WuXi Biologics